<DOC>
	<DOC>NCT00471380</DOC>
	<brief_summary>Double blind, crossover randomized, multicentric study to compare efficacy and tolerability of concomitant administration of travoprost and brinzolamide versus timolol-dorzolamide fixed combination in patients with glaucoma or ocular hypertension</brief_summary>
	<brief_title>A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Brinzolamide</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Written informed consent Diagnosis of bilateral Primary open angle glaucoma or ocular hypertension Intra Ocular Pressure above 19 millimeters mercury at screening visit at 8:00 AM Stable visual field in last 6 months 6 weeks wash out from previous topical medications Age</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>